Skip to product information
1 of 1

Invivo anti-human CD47 Recombinant mAb

Invivo anti-human CD47 Recombinant mAb

Catalog Number: S0B7031 Application: ELISA, WB Reactivity: Human Conjugation: Unconjugated Brand: Starter
Price:
Regular price $170 USD
Regular price Sale price $170 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen CD47
Synonyms Leukocyte surface antigen CD47; Antigenic surface determinant protein OA3; Integrin-associated protein (IAP); Protein MER6; MER6
Location Cell membrane
Accession Q08722
Clone Number S-3901
Antibody Type Mouse mAb
Isotype IgG1,k
Application ELISA, WB, in vitro CD47 neutralization, in vivo CD47 neutralization in human tumor xenograft models or humanized mice
Reactivity Hu
Purification Protein G
Concentration 5 mg/ml
Purity >95% (Determined by SDS-PAGE)
Endotoxin <1EU/mg
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS pH7.4, containing no preservative

Stability & Storage

2 to 8 °C for 2 weeks under sterile conditions;
-20 °C for 3 months under sterile conditions;
-80 °C for 24 months under sterile conditions.
Please avoid repeated freeze-thaw cycles.

Dilution


application dilution species
WB 1:1000 Hu

Background

CD47, also known as integrin-associated protein, is a ubiquitously expressed cell surface receptor that belongs to the immunoglobulin superfamily. It is widely known for its role in preventing macrophage-mediated phagocytosis by interacting with signal regulatory protein alpha (SIRPα) on phagocytic cells. This “don’t eat me” signal is crucial for the survival of healthy cells, but cancer cells often overexpress CD47 to evade immune attack. In addition to its role in immune regulation, CD47 is involved in various cellular processes, including cell adhesion, migration, and the regulation of autophagy and cell death. For instance, it can regulate the migration of immune cells like neutrophils and dendritic cells, and its interaction with thrombospondin-1 (TSP-1) can induce apoptosis in certain cell types. Due to its significant role in cancer immunotherapy, CD47 has become an important target for developing new therapeutic strategies.

Picture

Western Blot

WB result of Invivo anti-human CD47 Recombinant mAb
Primary antibody: Invivo anti-human CD47 Recombinant mAb at 1/1000 dilution
Lane 1: CD47 His Tag Protein, Mouse 10 ng
Lane 2: CD47 His Tag Protein, Human 10 ng
Secondary antibody: Goat Anti-mouse IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 35 kDa
Observed MW: 25-36 kDa